This review paper examines the critical role of venture capital and evolving biotech investment trends in driving therapeutic innovation from early stage discovery through to commercialization. It provides an overview of the biotech ecosystem, detailing key stakeholders and the innovation pipeline, followed by an analysis of venture capital’s unique role in funding high risk, high reward biotech ventures. Historical and recent investment patterns are explored, highlighting geographic hotspots and emerging areas such as gene therapy and mRNA technology. The paper also discusses the impact of investment on innovation speed and scale, while addressing challenges including regulatory complexity, long development timelines, and ethical concerns. Finally, emerging financing models, technological advances like artificial intelligence, and global collaboration are presented as future opportunities. The review concludes with strategic recommendations to foster a sustainable and inclusive biotech investment environment that accelerates the translation of scientific discoveries into life changing therapies.